Reliance Life Sciences

Reliance Life Sciences

India - Navi Mumbai
Biotechnology1 H-1B visas (FY2023)

Focus: Biosimilars

Reliance Life Sciences is a life sciences company focused on Biosimilars.

OncologyHematology
Open Jobs
0

Products & Portfolio (5)

AZACITIDINE
azacitidine
Post-LOE
INTRAVENOUS, SUBCUTANEOUS · POWDER
Nucleic Acid Synthesis Inhibitors
refractory anemia with ringed sideroblasts (if accompanied by neutropeniathrombocytopeniarequiring transfusions)+5 more
2025
30
BORTEZOMIB
bortezomib
Post-LOE
INTRAVENOUS, SUBCUTANEOUS · INJECTABLE
Proteasome Inhibitors
myelomalymphoma
2022
30
CAPECITABINE
capecitabine
Post-LOE
ORAL · TABLET
Nucleic Acid Synthesis Inhibitors
metastatic colorectal cancera component of a combination chemotherapy regimenmetastatic breast cancer+9 more
2020
30
DECITABINE
decitabine
Post-LOE
INTRAVENOUS · INJECTABLE
methyltransferase, causing hypomethylation of DNA and cellular differentiation or apoptosis. Decitabine inhibits DNA methylation in vitro , which is achieved at concentrations that do not cause major suppression of DNA synthesis. Decitabine-induced hypomethylation in neoplastic cells may restore normal function to genes that are critical for the control of cellular differentiation and proliferation. In rapidly dividing cells, the cytotoxicity of decitabine may also be attributed to the formation of covalent adducts between DNA methyltransferase and decitabine incorporated into DNA. Non-proliferating cells are relatively insensitive to decitabine.
untreatedde novosecondary MDS of all French-American-British subtypes (refractory anemia+9 more
2025
30
PEMETREXED DISODIUM
pemetrexed disodium
Post-LOE
INTRAVENOUS · POWDER
folate-dependent metabolic processes essential for cell replication. In vitro studies show that pemetrexed inhibits thymidylate synthase (TS), dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase (GARFT), which are folate-dependent enzymes involved in the de novo biosynthesis of thymidine and purine nucleotides. Pemetrexed is taken into cells by membrane carriers such as the reduced folate carrier and membrane folate binding protein transport systems. Once in the cell, pemetrexed is converted to polyglutamate forms by the enzyme folylpolyglutamate synthetase. The polyglutamate forms are retained in cells and are inhibitors of TS and GARFT.
non-small cell lung cancerlung cancer
2022
30

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 5 approved products
Top TAs: Oncology, Hematology
H-1B (2023): 1 approval
Portfolio Health
Post-LOE5 (100%)
5 total products
Therapeutic Area Focus
Oncology
5 marketed
Hematology
2 marketed
Marketed
Pipeline

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub